RARA and myeloid sarcoma: For patients without atypical promyelocytes in the peripheral blood and bone marrow, and with no cytogenetic abnormalities, the detection of PML::RARA transcripts or RARA rearrangements in MS tissues via qPCR or FISH becomes the key diagnostic criterion.